The effects of short-term, rapid glycemic control on the peroneal nerve function and serum VCAM-1 and AGE in type 2 diabetic patients in Malaysia

Indian Journal of Medical Sciences

Volumn 63, Issue 4, 2009, Pages 131-138

  Norlinah, M ^a   Hamizah, R ^a   Md Isa, S ^a   Wan Nazaimoon, W ^b   Khalid, B A K ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Cell adhesion molecules; Diabetic nephropathies

Indexed keywords

ACARBOSE; ADVANCED GLYCATION END PRODUCT; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; ISOPHANE INSULIN; METFORMIN; NEUTRAL INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MALAYSIA; MALE; MOTOR NERVE CONDUCTION; NERVE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERONEUS NERVE; SINGLE BLIND PROCEDURE; TREATMENT DURATION;

ADMINISTRATION, ORAL; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALAYSIA; MALE; MIDDLE AGED; NEURAL CONDUCTION; PERONEAL NERVE; PERONEAL NEUROPATHIES; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CELL ADHESION MOLECULE-1;

EID: 67650948506     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.49365     Document Type: Article

References (23)

1. Mimi O, Teng CL, Chia YC. The prevalence of diabetic peripheral neuropathy in an outpatient setting. Med J Malaysia 2003;58:533-538 (Pubitemid 38315812)
2. The Diabetes Control and Complications Trials Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
4. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular disease and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998;317:703-713
5. Gregersen G. Variations in motor conduction velocity produced by acute changes of metabolic state in diabetic patients. Diabetologia 1968;4: 273-277
6. King RH. The role of glycation in the pathogenesis of diabetic polyneuropathy J Clin Pathol Mol Pathol 2001;54:400-408
7. Vlassara H, Brownlee M, Cerami A. Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 1983;32:670-674
8. Norlinah MI, Khalid BA. Adhesion molecules in diabetic neuropathy. J Asean Fed Endocr Soc 2003;21:1-4
9. Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14: 506-512
10. Fasching P, Waldhausl W, Wagner OF. Elevated circulating adhesion molecules in NIDDM - potential mediators in diabetic macroangiopathy. Diabetologia 1996;39:1242-1244 (Pubitemid 26319954)
11. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthase in diabetic neuropathy, vascular disease and foot ulceration. Diabetes 1998;47: 457-463 (Pubitemid 28104210)
12. Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhausl W, et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocr Metab 1996;81:4313-4317 (Pubitemid 26412035)
13. Schmidt AM, Crandall J, Hori O, Cao R, Lakatta E. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: A marker of vascular dysfunction and progressive vascular disease. Br J Haematol 1996;92:747-750 (Pubitemid 26076776)
14. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 1994;72:979-984
15. Jude EB, Abbott CA, Young MJ, Anderson SG, Douglas JT, Boulton AJ. The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy. Diabetologia 1998;41:330-336 (Pubitemid 28254828)
16. Nakayama H, Taneda S, Mitsuhashi T, Kuwajima S, Aoki S, Kuroda Y, et al. Characterisation of antibodies to advanced glycosylation end products on protein. J Immunol Methods 1991;140:119-125
17. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17: 1281-1289 (Pubitemid 24324972)
18. Allgrove J, Cockrill BL. Fructosamine or glycated haemoglobin as a measure of diabetic control? Arch Dis Child 1988;63:418-422
19. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy in diabetes. J Clin Invest 1995;96:1395-1403
20. Biessels GJ, Cristino NA, Rutten GJ, Hamers FP, Erkelens WD, Gispen WH. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats: Course of development and effects of insulin treatment. Brain 1999;122:757-768
21. Ferreira LD, Huey PU, Pulford BE, Ishii DN, Eckel RH. Sciatic nerve Lipoprotein Lipase is reduced in streptozocin-induced diabetes and corrected by insulin. Endocrinology 2002:143:1214-1217
22. Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologica 2004;47:532-536 (Pubitemid 38491250)
23. Ryysy L, Yki-Järvinen H. Improvement of glycemic control by 1 year of insulin therapy leads to a sustained decrease in sE-Selectin concentrations in type 2 diabetes. Diabetes Care 2001;24: 549-554 (Pubitemid 32198428)